ask="0.8000"
ask_size="3000"
average_daily_volume="19718"
bid="0.7000"
bid_size="100"
book_value="0.2800"
change="-0.0641"
change_from_200_day_moving_average="-0.2053"
change_from_50_day_moving_average="0.0322"
change_from_52_week_high="-0.8898"
change_From_52_week_low="0.1901"
change_in_percent="-8.3879%"
close="0.7001"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2600"
ebitda="-2.11M"
eps_estimate_current_year="-0.0200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0200"
ex_dividend_date="N/A"
float_shares="9122000"
high="0.8400"
high_52_weeks="1.5899"
last_trade_date="1/20/2017"
last_trade_price="0.7001"
last_trade_size="397"
last_trade_time="4:00pm"
low="0.7000"
low_52_weeks="0.5100"
market_capitalization="9.38M"
moving_average_200_day="0.9054"
moving_average_50_day="0.6679"
name="XTL Biopharmaceuticals Ltd. - A"
notes="N/A"
one_year_target_price="6.0000"
open="0.8000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-22.6781%"
percent_change_from_50_day_moving_average="+4.8244%"
percent_change_from_52_week_high="-55.9658%"
percent_change_from_52_week_low="+37.2745%"
previous_close="0.7642"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.7293"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="13400000"
short_ratio="0.4000"
stock_exchange="NCM"
symbol="XTLB"
volume="186913"
weeks_range_52="0.5100 - 1.5899"
